Advancements in technology are significantly enhancing the ability to customize cancer treatments. High-throughput sequencing, artificial intelligence, and machine learning are enabling more precise analyses of genetic data. These technologies help in predicting how a patient will respond to specific treatments and in identifying new therapeutic targets.
